MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to produce the bulk drug substance for its HPV vaccine Gardasil.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback